CSK INHIBITION OF C-SRC ACTIVITY REQUIRES BOTH THE SH2 AND SH3 DOMAINS OF SRC

被引:249
|
作者
SUPERTIFURGA, G [1 ]
FUMAGALLI, S [1 ]
KOEGL, M [1 ]
COURTNEIDGE, SA [1 ]
DRAETTA, G [1 ]
机构
[1] EUROPEAN MOLEC BIOL LAB, DIFFERENTIAT PROGRAMME, MEYERHOFSTR 1, W-6900 HEIDELBERG, GERMANY
来源
EMBO JOURNAL | 1993年 / 12卷 / 07期
关键词
CSK; SH2; DOMAIN; SH3; SRC; TYROSINE KINASE;
D O I
10.1002/j.1460-2075.1993.tb05923.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein tyrosine kinase c-Src is negatively regulated by phosphorylation of Tyr527 in its carboxy-terminal tail. A kinase that phosphorylates Tyr527, called Csk, has recently been identified. We expressed c-Src in yeast to test the role of the SH2 and SH3 domains of Src in the negative regulation exerted by Tyr527 phosphorylation. Inducible expression of c-Src in Schizosaccharomyces pombe caused cell death. Co-expression of Csk counteracted this effect. Src proteins mutated in either the SH2 or SH3 domain were as lethal as wild type c-Src, but were insensitive to Csk, even though they were substrates for Csk in vivo. Peptide binding experiments revealed that Src proteins with mutant SH3 domains adopted a conformation in which the SH2 domain was not interacting with the tail. These data support the model of an SH2 domain-phosphorylated tail interaction repressing c-Src activity, but expand it to include a role for the SH3 domain. We propose that the SH3 domain contributes to the maintenance of the folded, inactive configuration of the Src molecule by stabilizing the SH2 domain - phosphorylated tail interaction. Moreover, the system we describe here allows for further study of the regulation of tyrosine kinases in a neutral background and in an organism amenable to genetic analysis.
引用
收藏
页码:2625 / 2634
页数:10
相关论文
共 50 条
  • [21] Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism
    Yolanda Pérez
    Mariano Maffei
    Ana Igea
    Irene Amata
    Margarida Gairí
    Angel R. Nebreda
    Pau Bernadó
    Miquel Pons
    Scientific Reports, 3
  • [22] Direct binding of C-terminal region of p130(Cas) to SH2 and SH3 domains of Src kinase
    Nakamoto, T
    Sakai, R
    Ozawa, K
    Yazaki, Y
    Hirai, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 8959 - 8965
  • [23] Distinct and opposite roles for SH2 and SH3 domains of v-src in embryo survival and hemangiosarcoma formation
    John C. Morgan
    John E. Majors
    Deni S. Galileo
    Clinical & Experimental Metastasis, 2005, 22 : 167 - 175
  • [24] Distinct and opposite roles for SH2 and SH3 domains of v-src in embryo survival and hemangiosarcoma formation
    Morgan, JC
    Majors, JE
    Galileo, DS
    CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (02) : 167 - 175
  • [25] Interactions between SH2 and SH3 domains
    Vihinen, M
    Smith, CIE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (02) : 351 - 356
  • [26] SH2 SH3 - EXPLORATION OF NEW DOMAINS
    MOORE, B
    SEROUSSI, G
    JOCHIM, B
    M S-MEDECINE SCIENCES, 1993, 9 (6-7): : 788 - 790
  • [27] Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation
    Ayrapetov, MK
    Nam, NH
    Ye, GF
    Kumar, A
    Parang, K
    Sun, GQ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) : 25780 - 25787
  • [28] Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs
    Chaturvedi, P
    Sharma, S
    Reddy, EP
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (06) : 3295 - 3304
  • [29] The role of backbone motions in ligand binding to the c-Src SH3 domain
    Wang, CY
    Pawley, NH
    Nicholson, LK
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 313 (04) : 873 - 887
  • [30] SUPPRESSION OF C-SRC ACTIVITY BY C-TERMINAL SRC KINASE INVOLVES THE C-SRC SH2-DOMAIN AND SH3-DOMAIN - ANALYSIS WITH SACCHAROMYCES-CEREVISIAE
    MURPHY, SM
    BERGMAN, M
    MORGAN, DO
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (09) : 5290 - 5300